About Canid
Canid is a company based in New York (United States) founded in 2020 by Pedro Sanchez De Lozada. It operates as a HealthTech and Managed Services. Canid has raised $11.5 million across 2 funding rounds from investors including FJ Labs, seedToB and Alumni Ventures. Canid offers products and services including Vaccine Management System, Inventory Automation, and Billing Support. Canid operates in a competitive market with competitors including FlexIG, VacTrack, MittVaccin, ImmunifyMe and AsepsisLife, among others.
- Headquarter New York, United States
- Founders Pedro Sanchez De Lozada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.5 M (USD)
in 2 rounds
-
Latest Funding Round
$10 M (USD), Series A
Jun 03, 2025
-
Investors
FJ Labs
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Canid
Canid offers a comprehensive portfolio of products and services, including Vaccine Management System, Inventory Automation, and Billing Support.
Vaccine operations are managed for pediatric practices efficiently.
Vaccine inventory is tracked and reordered automatically always.
Vaccine billing is handled to ensure full payment.
People of Canid
Unlock access to complete
Funding Insights of Canid
Canid has successfully raised a total of $11.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Canid
Canid has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include FJ Labs, seedToB and Alumni Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on marketplaces, gaming, web3, fintech, and multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital investing and portfolio management services for accredited investors.
|
Locked | Locked | Locked | |
|
Early-stage technology companies are funded by this venture capital firm.
|
Locked | Locked | Locked |
Investor details for Canid
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Canid
Investment portfolio details for Canid
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Canid
Detailed financials for Canid
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Canid Comparisons
Peer comparison for Canid
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Canid
Canid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as FlexIG, VacTrack, MittVaccin, ImmunifyMe and AsepsisLife, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Mobile app for tracking injections, health data, and treatment reminders.
|
|
| Locked | Locked | Locked |
Vaccination appointments are booked through a mobile application.
|
|
| Locked | Locked | Locked |
Mobile app for vaccination record monitoring and reminders is provided.
|
|
| Locked | Locked | Locked |
Mobile application to track child vaccination records
|
|
| Locked | Locked | Locked |
Provides a mobile app for vaccination tracking and evidence-based healthcare content.
|
Detailed competitors of Canid
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Canid
Complete news archive for Canid
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Canid
Canid was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Canid is headquartered in New York, United States. It is registered at New York, New York, United States.
Pedro Sanchez De Lozada is the current CEO of Canid. They have also founded this company.
Canid is a funded company, having raised a total of $11.5M across 2 funding rounds to date.
Vaccine operations are streamlined for small pediatric practices by Canid. Comprehensive support is provided in inventory management, purchasing, billing, and registry uploads. Automation of workflows is enabled to reduce manual tasks. Better care is facilitated through identifying under-vaccinated children and running outreach campaigns. The healthcare sector, specifically pediatric care, is targeted with solutions designed to ensure financial sustainability. Feedback from practices is incorporated to evolve the product continuously.
Canid's top competitors include MittVaccin, ImmunifyMe and VacTrack.
Canid offers Vaccine Management System, Inventory Automation, and Billing Support.
Canid has 7 investors. Key investors include FJ Labs, seedToB, Alumni Ventures, I2BF Global Ventures, and MKT1.